Novo Nordisk’s Wegovy wins FDA approval for heart health benefits

Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.Victoria Klesty | ReutersThe Food and Drug Administration approved Novo Nordisk's blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in people with obesity...

Read more...

Weight loss pill could become a best-in-class drug

Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company's experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity. The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for...

Read more...

Medicare should negotiate prices for 50 drugs each year

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023.Chris Kleponis | Bloomberg | Getty ImagesPresident Joe Biden on Wednesday said the federal Medicare program should negotiate prices for at least 50 prescription drugs each year, up from the current...

Read more...

Novo Nordisk Ozempic cuts risk of kidney disease progression

This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, eastern France. Sebastien Bozon | Afp | Getty ImagesNovo Nordisk's blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients, according to initial...

Read more...

CVS, Walgreens to start selling abortion pill mifepristone this month 

A container holding boxes of mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo Women's Clinic in Carbondale, Illinois, on April 20, 2023.Evelyn Hockstein | ReutersCVS and Walgreens will start selling the abortion pill mifepristone this month at certain pharmacy locations in states where...

Read more...

Medicare drug price negotiations: Judge rejects AstraZeneca challenge

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC.Anna Moneymaker | Getty ImagesA federal judge on Friday rejected AstraZeneca's legal challenge to Medicare's new power to negotiate the prices of...

Read more...